Lipid Genetics Linked to Type 2 Diabetes Risk

Genetic predisposition to low HDL cholesterol or high triglycerides associated with increased risk

MONDAY, Feb. 13 (HealthDay News) -- Individuals who are genetically predisposed to have low levels of high-density lipoprotein (HDL) cholesterol or high levels of triglycerides have an increased risk of developing type 2 diabetes, according to a study published online Feb. 7 in Diabetes.

To examine the association between genetic predisposition to dyslipidemia (based on established loci for blood lipids) and the risk of type 2 diabetes, Qibin Qi, Ph.D., from the Harvard School of Public Health in Boston, and colleagues analyzed data from 2,447 patients with type 2 diabetes from the Nurses' Health Study, and 3,052 control subjects free of diabetes from the Health Professionals Follow-up Study.

Based on genotype scores for low-density lipoprotein (LDL) cholesterol, HDL cholesterol, and triglycerides, the researchers found that only the HDL cholesterol and triglycerides scores were linearly associated with an increased risk of type 2 diabetes. For each point of the HDL cholesterol genotype score, there was a 3 percent increase in the risk of developing type 2 diabetes, and for each point on the triglyceride genotype score, the increase was 2 percent. Comparing the highest and lowest quartiles of genotype scores, the odds ratios for type 2 diabetes were 1.39 for HDL cholesterol and 1.19 for triglycerides.

"In conclusion, genetic predisposition to low HDL cholesterol or high triglycerides is related to elevated type 2 diabetes risk," Qi and colleagues write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events